Is MILEW or MRK a better dividend investment in 2026?

MILEW currently yields 3412.97% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: MILEW offers higher current income.

What is the dividend yield difference between MILEW and MRK?

MILEW has a forward dividend yield of 3412.97% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 3410.21 percentage points.

Home › Compare › MILEW vs MRK

MILEW vs MRK: Dividend Comparison 2026

MILEW yields 3412.97% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MILEW wins by $1559811747591.35M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MILEW

● Live price

3412.97%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1559811747591.41M

Annual income

$1,474,807,480,175,804,400.00

Full MILEW calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — MILEW vs MRK

📍 MILEW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MILEW	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MILEW + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MILEW pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MILEW

Annual income on $10K today (after 15% tax)

$290,102.39/yr

After 10yr DRIP, annual income (after tax)

$1,253,586,358,149,433,600.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, MILEW beats the other by $1,253,586,358,149,425,200.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MILEW + MRK for your $10,000?

MILEW: 50%MRK: 50%

100% MRK50/50100% MILEW

Portfolio after 10yr

$779905873795.73M

Annual income

$737,403,740,087,907,100.00/yr

Blended yield

94.55%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MILEW

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MILEW buys

MRK buys

No recent congressional trades found for MILEW or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMILEWMRK

Forward yield	3412.97% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$1559811747591.41M ✓	$56.8K
Annual income after 10y	$1,474,807,480,175,804,400.00 ✓	$9,798.13
Total dividends collected	$1553972652735.54M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MILEW vs MRK ($10,000, DRIP)

Year	MILEW Portfolio	MILEW Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$351,997	$341,296.93	$11,206	$366.19	+$340.8K → MILEW
2	$11,604,251	$11,227,614.06	$12,650	$502.35	+$11.59M → MILEW
3	$358,341,532	$345,924,984.17	$14,407	$694.19	+$358.33M → MILEW
4	$10,366,819,029	$9,983,393,589.63	$16,585	$967.82	+$10366.80M → MILEW
5	$281,017,295,054	$269,924,798,692.43	$19,342	$1,363.89	+$281017.28M → MILEW
6	$7,138,963,166,776	$6,838,274,661,068.20	$22,913	$1,947.19	+$7138963.14M → MILEW
7	$169,993,386,571,167	$162,354,695,982,716.50	$27,662	$2,823.89	+$169993386.54M → MILEW
8	$3,794,976,118,487,173	$3,613,083,194,856,024.50	$34,159	$4,173.35	+$3794976118.45M → MILEW
9	$79,443,240,575,328,160	$75,382,616,128,546,880.00	$43,337	$6,308.80	+$79443240575.28M → MILEW
10	$1,559,811,747,591,405,600	$1,474,807,480,175,804,400.00	$56,776	$9,798.13	+$1559811747591.35M → MILEW

MILEW vs MRK: Complete Analysis 2026

MILEW — Stock

Metromile, Inc. provides pay-per-mile car insurance service. It also licenses artificial intelligence claims platform to automate claims, reduce losses associated with fraud, and unlock the productivity of insurance carriers' employees; and offers Metromile Pulse, a wireless device that is plugged into the car's diagnostics port and transmits data over wireless cellular networks. The company was founded in 2011 and is based in San Francisco, California.

Full MILEW Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this MILEW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MILEW vs SCHD MILEW vs JEPI MILEW vs O MILEW vs KO MILEW vs MAIN MILEW vs JNJ MILEW vs ABBV MILEW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.